F. Hoffmann-La Roche Ltd:戦略・SWOT・企業財務分析

◆英語タイトル:F. Hoffmann-La Roche Ltd - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA8015499
◆発行会社(調査会社):MarketLine
◆発行日:2017年9月30日
◆ページ数:62
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

F. Hoffmann-La Roche Ltd – Strategy, SWOT and Corporate Finance Report
Summary

F. Hoffmann-La Roche Ltd – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

F. Hoffmann-La Roche (Roche or ‘the group’) is one of the leading research-focused healthcare groups in the world. It is engaged in the discovery, development and commercialization of innovative diagnostic and therapeutic products. Roche is headquartered in Basel, Switzerland.

Scope

- Detailed information on F. Hoffmann-La Roche Ltd required for business and competitor intelligence needs
- A study of the major internal and external factors affecting F. Hoffmann-La Roche Ltd in the form of a SWOT analysis
- An in-depth view of the business model of F. Hoffmann-La Roche Ltd including a breakdown and examination of key business segments
- Intelligence on F. Hoffmann-La Roche Ltd’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about F. Hoffmann-La Roche Ltd, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of F. Hoffmann-La Roche Ltd and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess F. Hoffmann-La Roche Ltd as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on F. Hoffmann-La Roche Ltd’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
F. Hoffmann-La Roche Ltd: Company Overview
F. Hoffmann-La Roche Ltd: Overview and Key Facts
F. Hoffmann-La Roche Ltd: Overview
F. Hoffmann-La Roche Ltd: Key Facts
F. Hoffmann-La Roche Ltd: Key Employees
F. Hoffmann-La Roche Ltd: Key Employee Biographies
F. Hoffmann-La Roche Ltd: Major Products and Services
F. Hoffmann-La Roche Ltd: Company History
F. Hoffmann-La Roche Ltd: Management Statement
F. Hoffmann-La Roche Ltd: Locations and Subsidiaries
F. Hoffmann-La Roche Ltd: Key Competitors
F. Hoffmann-La Roche Ltd: Company Analysis
F. Hoffmann-La Roche Ltd: Business Description
F. Hoffmann-La Roche Ltd: SWOT Analysis
F. Hoffmann-La Roche Ltd: SWOT Overview
F. Hoffmann-La Roche Ltd: Strengths
F. Hoffmann-La Roche Ltd: Weaknesses
F. Hoffmann-La Roche Ltd: Opportunities
F. Hoffmann-La Roche Ltd: Threats
F. Hoffmann-La Roche Ltd: Corporate Financial Deals Activity
F. Hoffmann-La Roche Ltd: Financial Deals Overview
F. Hoffmann-La Roche Ltd: Targets and Partners
F. Hoffmann-La Roche Ltd: Top Deals 2013 – 2017YTD*
F. Hoffmann-La Roche Ltd: Mergers and Acquisitions
F. Hoffmann-La Roche Ltd: Corporate Venturing
F. Hoffmann-La Roche Ltd: Partnership
F. Hoffmann-La Roche Ltd: Recent Developments
F. Hoffmann-La Roche Ltd: News and Events Summary
F. Hoffmann-La Roche Ltd: Corporate Governance
F. Hoffmann-La Roche Ltd: Financial Performance
F. Hoffmann-La Roche Ltd: IT Spending Announcements
F. Hoffmann-La Roche Ltd: Market Developments
F. Hoffmann-La Roche Ltd: Research & Development
Appendix
Contact Us
Methodology
Definitions
About MarketLine

List of Tables
Table 1: F. Hoffmann-La Roche Ltd: Key Facts
Table 2: F. Hoffmann-La Roche Ltd: Key Employees
Table 3: F. Hoffmann-La Roche Ltd: Locations and Subsidiaries
Table 4: F. Hoffmann-La Roche Ltd: Key Competitors
Table 5: F. Hoffmann-La Roche Ltd: Deal Activity by Deal Type - Volume (TTM*)
Table 6: F. Hoffmann-La Roche Ltd: Deal Activity by Deal Type - Volume (2013 - YTD*2017)
Table 7: F. Hoffmann-La Roche Ltd: Targets and Partners
Table 8: F. Hoffmann-La Roche Ltd: Top Deals 2013 - 2017YTD*
Table 9: F. Hoffmann-La Roche Ltd: M&A Volume and Value Trend (2013 - YTD*2017)
Table 10: F. Hoffmann-La Roche Ltd: Corporate Venturing Volume and Value Trend (2013 - YTD*2017)
Table 11: F. Hoffmann-La Roche Ltd: Corporate Venturing by Geography (2013 - YTD*2017)
Table 12: F. Hoffmann-La Roche Ltd: Partnership Volume and Value Trend (2013 - YTD*2017)
Table 13: F. Hoffmann-La Roche Ltd: Partnership Trend by Deal Type (2013 - YTD*2017)
Table 14: F. Hoffmann-La Roche Ltd: News and Events Summary
Table 15: F. Hoffmann-La Roche Ltd: Corporate Governance
Table 16: F. Hoffmann-La Roche Ltd: Financial Performance
Table 17: F. Hoffmann-La Roche Ltd: IT Spending Announcements
Table 18: F. Hoffmann-La Roche Ltd: Market Developments
Table 19: F. Hoffmann-La Roche Ltd: Research & Development

★海外企業調査レポート[F. Hoffmann-La Roche Ltd:戦略・SWOT・企業財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • USV Pvt Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary USV Pvt Ltd (USV) is a healthcare company that offers pharmaceutical products. The company’s products include active pharmaceutical ingredients, biosimilars, injectables, ophthalmics, peptides and solid orals. Its biosimilars products comprise PEG-filgrastim, teriparatide, somatropin, filgra …
  • Saneca Pharmaceuticals as:製薬・医療:M&Aディール及び事業提携情報
    Summary Saneca Pharmaceuticals as (Saneca Pharma) is a contract development and manufacturing organization that develops and manufactures active pharmaceutical ingredients and finished dosage forms. The organization provides products such as API's; 2-aminotridecane adipate, atorvastatin calcium crys …
  • Aclara Technologies LLC:電力:M&Aディール及び事業提携情報
    Summary Aclara Technologies LLC (Aclara), a subsidiary of Hubbell Incorporated, is involved in designing, developing and commercializing Advanced Metering Infrastructure (AMI) solutions for data value management, customer communication and device networking activities. It provides an array of custom …
  • PhotoMedex Inc (PHMD)-製薬・医療分野:企業M&A・提携分析
    Summary PhotoMedex Inc (PhotoMedex) is a medical device company that provides dermatological solutions. The company offers Neova, Tricomin and IAMIN products. Its products are used in the treatment of skin diseases and conditions such as psoriasis, vitiligo, acne, actinic keratosis. PhotoMedex provi …
  • Lead Discovery Center GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Lead Discovery Center GmbH (LDC), a subsidiary of Max Planck Innovation GmbH is a biomedical research company that offers development of novel drugs and therapies. The company develops drugs and therapies for diseases such as neurodegenerative cardiovascular diseases, cancer, inflammatory di …
  • Goodrich Petroleum Corp (GDP):石油・ガス:M&Aディール及び事業提携情報
    Summary Goodrich Petroleum Corp (Goodrich) is an independent oil and gas company. It explores, develops and produces oil and natural gas from properties that include Tuscaloosa Marine Shale in Eastern Louisiana and Southwestern Mississippi, Haynesville Shale trend in north Louisiana and east Texas, …
  • Eneva SA (ENEV3):電力:M&Aディール及び事業提携情報
    Summary Eneva SA (Eneva), formerly MPX Energia SA, is an integrated energy company. The company offers power generation, energy commercialization, and exploration and production of hydrocarbons and natural gas. Its power generation portfolio includes fossil fuels such as coal and natural gas, and re …
  • Australian Vanadium Ltd (YRR):企業の財務・戦略的SWOT分析
    Summary Australian Vanadium Ltd (AVL), formerly Yellow Rock Resources Ltd, is a mining company that explores and develops titanium, vanadium, copper, gold, and uranium metals. The company’s projects include Gabanintha Gold Copper Project, The Australian Vanadium Project, Coates Vanadium Project, Now …
  • Nedbank Group Ltd (NED):企業の財務・戦略的SWOT分析
    Nedbank Group Ltd (NED) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Cynosure Inc (CYNO):企業の財務・戦略的SWOT分析
    Summary Cynosure Inc (Cynosure), a subsidiary of Hologic Inc, is a developer, manufacturer and supplier of light-based aesthetic and medical treatment systems. Its products facilitate non-invasive body contouring, skin revitalization and scar reduction, cellulite reduction, hair removal, gynecologic …
  • Thryv Holdings Inc (THRY):企業の財務・戦略的SWOT分析
    Thryv Holdings Inc (THRY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • West Corporation:企業の戦略的SWOT分析
    West Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • BioCision LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary BioCision LLC (BioCision) is a life science research and development company that develops products and solutions for process standardization. The company provides products such as cell cryopreservation systems, ice-free cooling systems, tube and plate temperature management systems, cell th …
  • OriGene Technologies Inc-医療機器分野:企業M&A・提携分析
    Summary OriGene Technologies Inc (OriGene) is a research tool company that develops cDNA. The company creates commercial collection of full-length human cDNAs in expression vector. It develops, manufactures and sells genome research and diagnostic products. OriGene’s products include qPCR reagents, …
  • Censa Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Censa Pharmaceuticals Inc (Censa Pharmaceuticals) is a pharmaceutical company that develops and commercializes therapeutics for the treatment of rare central nervous system (CNS) disorders. The company provides product pipeline such as therapies for the treatment of extremely rare disorders …
  • Lanco Infratech Ltd (LITL):企業の財務・戦略的SWOT分析
    Lanco Infratech Ltd (LITL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Tokyo Electron Device Ltd.:企業の戦略・SWOT・財務情報
    Tokyo Electron Device Ltd. - Strategy, SWOT and Corporate Finance Report Summary Tokyo Electron Device Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Zeta Petroleum Plc (ZTA):企業の財務・戦略的SWOT分析
    Summary Zeta Petroleum Plc (Zeta) is an oil and gas exploration and production company. The company explores, develops and produces natural gas and crude oil. It also owns and operates oil and gas assets such as Bobocu Gas Field, Suceava Concession, Jimbolia Oil Field, and Grivita Nord Oil Field. Ze …
  • Coherent Inc (COHR):企業の財務・戦略的SWOT分析
    Coherent Inc (COHR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Nippon Flour Mills Co., Ltd.
    Nippon Flour Mills Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Nippon Flour Mills Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆